scispace - formally typeset
F

Fanfei Kong

Researcher at Tongji University

Publications -  6
Citations -  318

Fanfei Kong is an academic researcher from Tongji University. The author has contributed to research in topics: Gene knockdown & Cancer research. The author has an hindex of 2, co-authored 2 publications receiving 235 citations.

Papers
More filters
Journal ArticleDOI

MiR-497 decreases cisplatin resistance in ovarian cancer cells by targeting mTOR/P70S6K1

TL;DR: The results demonstrated that overexpression of miR-497 sensitizes the resistant ovarian tumor to cisplatin treatment, and it is suggested that mi R-497 might be used as a therapeutic supplement to increase ovarian cancer treatment response to cis Platin.
Journal ArticleDOI

IGF2BP3 enhances the mRNA stability of E2F3 by interacting with LINC00958 to promote endometrial carcinoma progression

TL;DR: Wang et al. as discussed by the authors investigated the role of LINC00958 in regulating the function of IGF2BP3, an RNA binding protein involved in mRNA stability, and their clinical implications in EC.
Journal ArticleDOI

IGF2BP3 enhances the mRNA stability of E2F3 by interacting with LINC00958 to promote endometrial carcinoma progression

TL;DR: Wang et al. as discussed by the authors investigated the role of LINC00958 in regulating the function of IGF2BP3, an RNA binding protein involved in mRNA stability, and their clinical implications in EC.
Journal ArticleDOI

Nomograms Based on Fibrinogen, Albumin, Neutrophil-Lymphocyte Ratio, and Carbohydrate Antigen 125 for Predicting Endometrial Cancer Prognosis

TL;DR: In this article , the authors used preoperative levels of fibrinogen, albumin, neutrophil-lymphocyte ratio (NLR), and carbohydrate antigen 125 (CA125) for predicting patient survival.